IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes | Zendy

Mojgan Yazdanpanah | Zendy; Fakhredin A. SayedTabatabaei | Zendy; J. A. M. J. L. Janssen | Zendy; Ingrid Rietveld | Zendy; Albert Hofman | Zendy; Theo Stijnen | Zendy; Huibert A. P. Pols | Zendy; Steven W. J. Lamberts | Zendy; Jacqueline C.M. Witteman | Zendy; Cornelia M. van Duijn | Zendy

Open Access

IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes

Author(s) -

Mojgan Yazdanpanah,

Fakhredin A. SayedTabatabaei,

J. A. M. J. L. Janssen,

Ingrid Rietveld,

Albert Hofman,

Theo Stijnen,

Huibert A. P. Pols,

Steven W. J. Lamberts,

Jacqueline C.M. Witteman,

Cornelia M. van Duijn

Publication year - 2006

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.1.02276

Subject(s) - hazard ratio , medicine , type 2 diabetes , myocardial infarction , genotype , rotterdam study , diabetes mellitus , confidence interval , population , proportional hazards model , prospective cohort study , allele , polymorphism (computer science) , endocrinology , gastroenterology , biology , genetics , gene , environmental health

Previously we observed that non-carriers of the most common alleles of an IGF-I promoter polymorphism have low circulating IGF-I levels and an increased risk of developing myocardial infarction (MI), particularly in patients with type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research